BSE   23 May 13 | 12:00 AM 393.15 -37.95 (-8.8%) Mkt Price (Rs)   Chg Rs (Chg %) Code: 500359 Face Value: 5

NSE   23 May 13 | 12:00 AM 394.30 -36.75 (-8.53%) Mkt Price (Rs)   Chg Rs (Chg %) Code: RANBAXY

Performance 1 Week : Rs 475.10 (-17.25%) 1 Month : Rs 458.80 (-14.31%) 1 Year : Rs 501.10 (-21.54%)

Smart Charts | Add to my portfolio | Derivative

News 23 May 13 18:28 Collateral damage: Ranbaxy fiasco may hit India's image as cheap generic maker 12:44 Ranbaxy: Will it ever recover? 09:42 Ranbaxy tanks on DCGI investigation 00:55 Daiichi pursuing legal action on ex-shareholders 00:49 Ranbaxy may reduce global sales team 00:45 Street worries on Ranbaxy

Stock Summary

Shareholding Pattern Promoters 63.52 % Mutual Funds / UTI 1.95 % FI/Bank 0.27 % Insurance 7.82 % Others 0.00 % Govt 0.00 % FII 10.55 % Non-Institutions 13.80 % Depository Receipts 2.09 % Total 100.00 %

Key Financials (Rs cr) Mar 2013 Mar 2012 YOY Operating Income 2,500.55 3,781.31 -33.87 Total Expenses 2,345.65 2,690.18 -12.81 Operating Profit 154.90 1,091.13 -85.80 Other Income 144.26 405.44 -64.42 PBDIT 299.16 1,496.57 -80.01 PBT 165.27 1,385.89 -88.07 Adjusted Net Profit 125.76 902.04 -86.06

Peer Group Company Last (Rs) Chg (%) Mkt Cap (Rs cr) Cipla 415.00 -0.06 33,321 Glaxosmit Pharma 2,279.50 0.09 19,308 Cadila Health. 787.50 0.12 16,124 Glenmark Pharma. 572.00 1.60 15,493 Wockhardt 1,315.25 -20.00 14,413

Funds Owning this Stock Scheme Name Value (Rs cr) Reliance Growth Fund - (G) 163.09 Reliance Growth Fund - Inst (G) 126.74 Reliance Growth Fund - Direct (G) 124.57 Reliance Equity Opportunities Fund - Direct (G) 104.55 Reliance Equity Opportunities Fund (G) 90.54

Announcements

Research Reports Date Broker Action Price (Rs) Report 07/03 Angel Broking Neutral 400 17/11 Indianivesh Neutral 549 17/11 Angel Broking Neutral 542 03/09 Edelweiss Reduce 548 17/08 Angel Broking Neutral 483